Device Trial Radar · NCT07393880
Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Jun 30, 2026
Primary completion
Sep 30, 2028
Study completion Jan 30, 2029
Sponsor
- Lead sponsor
- University of Dublin, Trinity CollegeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 6, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study tests whether pairing non-invasive stimulation of the greater occipital nerve (NITESGON) with an attentionally demanding auditory frequency discrimination training task reduces tinnitus loudness and tinnitus-related distress. One hundred adults with chronic tonal tinnitus will be randomised to one of four groups in a 2×2 factorial design: real versus sham NITESGON and active versus passive listening during auditory stimulation. Participants complete eight sessions across four weeks, with outcomes assessed at baseline, end of treatment, 28 days post-treatment, and 6 months post-treatment.
Conditions
- Tinnitus, Subjective
- Tinnitus
- Chronic Tinnitus
Interventions
Real NITESGONDevice
Real NITESGON is delivered transcutaneously via two saline-soaked sponge electrodes (35 cm² each) positioned bilaterally over the C2 dermatomes to target the greater occipital nerve. Stimulation consists of a constant direct current of 1.5 mA (tDCS), ramped up over 30 seconds and ramped down over 5 seconds. It is administered concurrently with the task for approximately 45 minutes per session, across eight sessions (2/week) over 4 weeks.
Sham NITESGONDevice
Sham NITESGON is delivered using two saline-soaked sponge electrodes (35 cm² each) positioned bilaterally over the C2 dermatomes. The sham condition mimics real stimulation sensations via a 30-second ramp-up followed by a brief ramp-down, with no sustained current thereafter. Sham is administered concurrently with the task for \~45 minutes per session, across eight sessions (2/week) over 4 weeks.
Active ListeningBehavioral
ADT is delivered using a three-interval, three-alternative forced-choice (3I-3AFC) frequency discrimination task. Standard tone frequencies are individually selected using equivalent rectangular bandwidth (ERB) spacing, centred on each participant's dominant tinnitus pitch, with five frequencies positioned at -5, -3, -1, +1, and +3 ERB relative to the tinnitus pitch. Frequencies are restricted to the range of 250-13,000 Hz. Tones are presented binaurally via headphones, with presentation levels individually calibrated using audiometric thresholds and frequency-specific reference equivalent threshold sound pressure levels (RETSPLs), subject to the protocol's sound pressure level limits.
Passive Listening (Control)Behavioral
VisDT uses a three-interval, three-alternative forced-choice (3I-3AFC) paradigm with Gabor patches (sinusoidal gratings windowed by a Gaussian envelope) of fixed spatial frequency (6 cycles/degree) and fixed spatial spread. On each trial, one interval contains an orientation deviant relative to the standard. During VisDT, participants attend to the visual task while concurrent binaural tones are presented passively using a predetermined, non-adaptive schedule. Auditory frequencies are individually selected using equivalent rectangular bandwidth (ERB) spacing, centred on each participant's dominant tinnitus pitch, with five frequencies positioned at -5, -3, -1, +1, and +3 ERB relative to the tinnitus pitch. Frequencies are restricted to 250-13,000 Hz, and presentation levels are individually calibrated using audiometric thresholds and frequency-specific reference equivalent threshold sound pressure levels (RETSPLs), subject to the protocol's sound pressure level limits.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Tinnitus Loudness (Visual Analogue Scale, VAS 0-100)Time frame: Baseline visit, end of treatment at 4 weeks, 28 days post-treatment, and 6 months post-treatment.
- Tinnitus Functional Index (TFI, 0-100)Time frame: Baseline visit, end of treatment at 4 weeks, 28 days post-treatment, and 6 months post-treatment.
- Tinnitus Handicap Inventory (THI, 0-100)Time frame: Baseline visit, end of treatment at 4 weeks, 28 days post-treatment, and 6 months post-treatment.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Trinity College Institute of Neuroscience (TCIN)
Dublin, Dublin, Ireland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.